FDA Authorizes First-Of-Its-Kind Robotic Blood Draw Device
The U.S. Food and Drug Administration today authorized the Aletta, the first standalone robotic device that can draw blood from…
August 2026
FDA Approves First Therapy for Patients aged 8 years and older with Glycogen Storage Disease Type Ia
The U.S. Food and Drug Administration today issued an accelerated approval for Genglycos (pariglasgene brecaparvovec-opnr) as the first-ever treatment for…